André Baruchel

18PUBLICATIONS
107CO-AUTHORS
Medical infection agents (incl. prions)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Infant and child healthPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Apr 21, 2026
Genomic fusion breakpoints for DNA-based measurable residual disease monitoring in pediatric acute lymphoblastic leukemia.

|Feb 24, 2026
Characteristics and outcome determinants in children, adolescents and young adults who failed tisagenlecleucel for B-cell acute lymphoblastic leukemia.

Nicolas Lecornec, Florence Rabian, Marie-Emilie Dourthe

|Dec 02, 2025
Selection of isatuximab dosing regimen in pediatric patients with leukemia using population pharmacokinetics.

Claire Brillac, Dorothée Sémiond, Corina Oprea

|Nov 03, 2025
Isatuximab in combination with chemotherapy for pediatric patients with relapsed/refractory acute lymphoblastic leukemia or acute myeloid leukemia: The ISAKIDS study.

André Baruchel, Karsten Nysom, Hyoung Jin Kang

|Aug 09, 2025
Towards methylation-based redefinition of TAL1 positive T-cell acute lymphoblastic leukaemia (T-ALL).

Charlotte Smith, Guillaume Charbonnier, Mathieu Simonin

|Aug 05, 2025
Prognostic impact of the PredicT-ALL classifier in the AALL0434 trial: a model combining NGS, MRD, and WBC at diagnosis.

Mathieu Simonin, Nicolas Boissel, Arnaud Petit

Pageof 3

Frequent Collaborators

5 joint publications

Arnaud Petit

5 joint publications

Susana Rives

4 joint publications

Aurélie Caye-Eude

4 joint publications

Jochen Buechner